Japan· JP-3999479G1026
アナキンラ（遺伝子組換え）
A medicinal product containing アナキンラ（遺伝子組換え）, registered in Japan by Ｓｗｅｄｉｓｈ Ｏｒｐｈａｎ Ｂｉｏｖｉｔｒｕｍ Ｊａｐａｎ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アナキンラ（遺伝子組換え）
- Manufacturer
- Ｓｗｅｄｉｓｈ Ｏｒｐｈａｎ Ｂｉｏｖｉｔｒｕｍ Ｊａｐａｎ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
アナキンラ（遺伝子組換え） in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKINERETSwedish Orphan Biovitrum AB (publ), Stockholm
- SwedenKineret 100 mg Injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- BelgiumKineret 100 mgSwedish Orphan Biovitrum (Publ)
- FinlandKineretSwedish Orphan Biovitrum AB (publ)
- FranceKINERET 100 mg/0,67 mL, solution injectable en seringue préremplieSWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
- United KingdomKineret 100mg/0.67ml solution for injection pre-filled syringesSwedish Orphan Biovitrum Ltd
- IrelandKineret 100 mg/0.67 ml solution for injection in pre-filled syringeSwedish Orphan Biovitrum AB
- IcelandKineret*Swedish Orphan Biovitrum AB (publ)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kineret
- Liechtenstein · Kineret
- Norway · Kineret
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/925434f3-d436-430c-b7b5-a135c8e275a4 GET /v1/drugs/925434f3-d436-430c-b7b5-a135c8e275a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１００ｍｇ０．６７ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999479G1026",
"category": "注射薬",
"price_yen": 5044,
"generic_name": "アナキンラ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": "5044"
}See everything about アナキンラ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.